Skip to main content

Table 2 Clinical, hormonal and metabolic features of PCOS study subjects.

From: Improving inter-observer variability in the evaluation of ultrasonographic features of polycystic ovaries

 

Mean ± SEM

Range

Normal Values

Age (yr)

28.5 ± 0.7

19 – 35

-

BMI (kg/m2)

30.1 ± 1.4

19.4 – 45.0

20 – 25

Waist Circumference (cm)

95.3 ± 3.1

70.0 – 140.0

< 88

Menstrual Cycle Length (d)

106 ± 17

25 – 365

21 – 35

mFG Score

9.6 ± 1.1

0 – 24

< 6

Testosterone (nmol/L)

2.3 ± 0.2

0.75 – 5.0

< 2.5

SHBG (nmoll/L)

46.7 ± 4.2

13.0 – 97.2

18 – 114

Free Androgen Index

6.1 ± 0.7

1 – 19

< 5

DHEA-S (μmol/L)

5.1 ± 0.3

2.2 – 8.8

0.9 – 12.0

17OH-Progesterone (nmol/L)

3.8 ± 0.4

1.2 – 11.2

0.3 – 12.1

LH:FSH Ratio

2.3 ± 0.3

0.6 – 7.7

< 2

Cortisol (nmol/L)

303 ± 23

130 – 640

130 – 640

Prolactin (μg/L)

13.1 ± 0.9

4.4 – 20.0

3.0 – 20.0

TSH (mIU/L)

1.9 ± 0.2

0.5 – 4.8

0.3 – 5.5

Fasting Glucose (mmol/L)

4.9 ± 0.1

4.2 – 6.7

< 6.1

Fasting Insulin (pmol/L)

78.1 ± 9.4

21.0 – 185.0

< 100

HOMA-IR

3.0 ± 0.4

0.7 – 8.1

< 3

  1. Normative values for the local health region are provided. Body mass index (BMI), modified Ferriman-Gallwey (mGF), sex hormone binding globulin (SHBG), dehydroepiandrosterone sulfate (DHEA-S), follicle stimulating hormone (FSH), luteinizing hormone (LH), thyroid stimulating hormone (TSH), homeostatic model assessment of insulin resistance (HOMA-IR).